Generic Name: Ambrisentan
Brand Name: Volibris
Manufacturer: GlaxoSmithKline Inc.
Indications: Pulmonary arterial hypertension (WHO class II and III)
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: December 17, 2008
Recommendation Type: List with clinical criteria and/or conditions